| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 28, 2019Virtual Press Office and PR Newswire: General Trade show news
Marshalls Traditional Healthcare, the company behind Lays Tissue Oil Spray, will exhibit at the International Beauty Show (IBS) in New York next month. IBS, which is the top trade show for beauty...
-
Feb 28, 2019Mobile World Congress Exhibitor News, photos, videos and more
At the 2019 Mobile World Congress, Vietnam's largest mobile network operator Viettel Group unveiled three new technological solutions to help the seafood industry tackle the challenges that they...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Sungrow, the global leading inverter solution supplier for renewables, unveiled its new PV inverter solutions, turnkey energy storage systems (ESS) as well as floating PV systems tailored for...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today announced that Luis Gutierrez, CEO Prologis Property Mexico and Jorge Girault, SVP...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that new data from five abstracts on the...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced two...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Bolt Biotherapeutics, Inc., a biotechnology company focused on unleashing the power of the immune system to achieve anti-tumor immunity in patients with its promising Immune-Stimulating Antibody...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Nektar Therapeutics (Nasdaq: NKTR) today announced several preclinical data presentations for its immuno-oncology pipeline candidates, bempegaldesleukin* (NKTR-214), a CD122-preferential IL-2...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics, will present pre-clinical data on BA3071 and...
